Skip to contentSkip to filters

We use cookies for analytics.

Topic: A-I RNA editing

ePoster
1 ePoster

In Neuroscience

ADAR therapeutic to tackle neurodegenerative disorders

Matteo Bertoli, Luca La via, Alice Filippini, Veronica Mutti, Giulia Carini, Elona Ndoj, Isabella Russo, Alessandro Barbon · FENS Forum 2024

Adenosine Deaminases Acting on RNA (ADAR) enzymes catalyse the conversion of adenosine (A) to inosine (I) within double-stranded RNA (dsRNA) molecules. This mechanism, known as A-I RNA editing, is able to modulate gene expression, RNA stability and protein function.Recently, new therapeutic approaches based on site-directed RNA editing (SDRE) leverage the recoding ability of ADAR to correct pathogenic G to A nucleotide mutations. SDRE allows for the manipulation of genetic information without causing damage to the genome. G-to-A point mutations make up nearly 30% of the pathogenic single nucle

ePoster · Neuroscience